Prabhakar Boddu - Concepedia

Author

Prabhakar Boddu

Also Known As

Boddu Prabhakar, Prabhakar Boddu

Publications

507

Citations

H-Index

Concepts

All Affiliations

Prabhakar Boddu is an author at Osmania General Hospital specializing in medicine, gastroenterology, and hepatology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	445
2	Gastroenterology	3	3	422
3	Public Health	1	1	130
4	Emergency Medicine	1	1	27
5	Epidemiology	1	1	130

Prabhakar Boddu

Publications

475

Citations

H-Index

Page 1

	Year	Citations
Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis Gary R. Lichtenstein, Michael A. Kamm, Prabhakar Boddu, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesTwice-daily Mmx MesalamineMucosal ImmunologyImmunology	2007	265
Etiology and mode of presentation of chronic liver diseases in India: A multi centric study Partha Sarathi Mukherjee, Vishnubhatla Sreenivas, Deepak Amarapurkar, PLoS ONE GastroenterologyPathologyHepatitis BFatty Liver DiseaseCirrhosis	2017	130
Dna Methylation in Esophageal Diseases Including Cancer: Special Reference to hMLH1 Gene Promoter Status Vasavi Mohan, Shivani Ponnala, Kusumanjali Gujjari, Tumori Journal	2006	30
Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis. Philip Abraham, Jude Rodriques, Nivedita Moulick, PubMed Acute PancreatitisSevere Acute PancreatitisNew Organ DysfunctionAcute Pancreatitis.toPharmacology	2013	27
Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial K T Shenoy, Leena Kondarappassery Balakumaran, Philip Mathew, Journal of Clinical and Experimental Hepatology Metabolic Associated SteatohepatitisMetadoxine Versus PlaceboHepatologyMedicineRandomized Controlled Trial	2014	23

Page 1